Author Archives: admin

‘Research, Innovative treatments and Barriers for innovation including liability’: Keele University, 14 September 2017

This seminar is part of an ESRC funded series which will examine the relationship between the regulation of research, and of innovative treatments and the effects on innovation. Issues to be addressed include the distinction between innovative treatment and research; the responsibilities of the scientist versus the clinician in translation of innovative therapies; the relative […]

Joanna Manning, ‘Does the Law on Compensation for Research-Related Injury in the UK, Australia, and New Zealand Meet Ethical Requirements?’

Abstract: Despite a consensus that society owes an ethical obligation to compensate for research-related injury, and that no-fault is the best ethical response, an assessment of the compensation arrangements in place in the UK, Australia and New Zealand shows that in general compensation arrangements fall below this ethical expectation. Most subjects rely on ex gratia […]

Brian Fitzpatrick, ‘Do Class Actions Deter Wrongdoing?’

Abstract: I and other scholars have long pointed to the deterrence virtue of the class action to justify its existence even when it was doubtful that it furthered its other purposes, such as compensation or litigation efficiency. In recent years, critics have argued that class actions may not offer even this virtue. Some argue that […]

‘Why the CJEU cheese copyright case is anything but cheesy’

“A few months ago a Dutch court (Arnhem-Leeuwarden Court of Appeal) made a reference for a preliminary ruling to the Court of Justice of the European Union (CJEU), asking whether the EU copyright system – notably Directive 2001/29 (the InfoSoc Directive) – allows Member States to extend copyright protection to something like the taste of […]

Clifford Villa, ‘Is The “Act of God” Dead?’

Abstract: In more than twenty years with the US Environmental Protection Agency (EPA) before joining the legal academy, I saw many communities affected by fires, floods, hurricanes, earthquakes, and other natural disasters. However, I never saw a case where the act of God defense prevailed against environmental liability. Confirming this personal experience, I later learned […]

Peter Lee, ‘Toward a Distributive Agenda for US Patent Law’

Abstract: As commonly understood, the US patent system is a utilitarian regime that employs exclusive rights and market incentives to promote technological progress. Unlike international and foreign regimes, the domestic patent system less explicitly addresses non-utilitarian issues such as access, equity, and distributive justice in conferring and enforcing exclusive rights. This Article, however, challenges this […]

‘The Real World’

Karen Bradshaw, Settling for Natural Resource Damages, 40 Harvard Environmental Law Review 211 (2016); James W Coleman, How Cheap Is Corporate Talk? Comparing Companies’ Comments on Regulations with Their Securities Disclosures, 40 Harvard Environmental Law Review 48 (2016). My very first law professor, Bob Ellickson, once said to my Torts class: ‘You know how law […]

Lawrence Solum, ‘Virtue as the End of Law: An Aretaic Theory of Legislation’

Abstract: This paper sketches an aretaic theory of legislation. Such a theory posits the flourishing of humans and their communities as the end or telos of law. The paper argues for a Neo-Aristotelian conception of human flourishing as a life of social and rational activities that express the human excellences or virtues. Because a flourishing […]

Louis Kaplow, ‘Optimal Design of Private Litigation’

Abstract: This article translates and extends Becker (1968) from public law enforcement to private litigation by examining optimal legal system design in a model with private suits, signals of case strength, court error, and two types of primary behavior: harmful acts that may be deterred and benign acts that may be chilled. The instruments examined […]

Chico and Taylor, ‘Using and Disclosing Confidential Patient Information and the English Common Law: What are the Information Requirements of a Valid Consent?’

Abstract: The National Health Service in England and Wales is dependent upon the flow of confidential patient data. In the context of consent to the use of patient health data, insistence on the requirements of an ‘informed’ consent that are difficult to achieve will drive reliance on alternatives to consent. Here we argue that one […]